TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
Primary objective:
To determine the rate of confirmed treatment failure and relapse with an intermittent
rifabutin-based regimen for the treatment of isoniazid and rifamycin-susceptible HIV-related
tuberculosis (TB).
Phase:
N/A
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborators:
US Department of Veterans Affairs VA Office of Research and Development